PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsArthritis
MeSH D001168 - arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007592:Joint diseases
4 Companies
2 Drugs
$
Success rate
D001168: 
Arthritis
15 Companies
8 Drugs
$
Success rate
D001169:Experimental arthritis
0 Companies
0 Drugs
Success rate
D001170:Infectious arthritis
36 Companies
7 Drugs
$
Success rate
D001171:Juvenile arthritis
135 Companies
25 Drugs
$
Success rate
D001172:Rheumatoid arthritis
227 Companies
82 Drugs
$
Success rate
D002805:Chondrocalcinosis
0 Companies
0 Drugs
Success rate
D006073:Gout
127 Companies
40 Drugs
$
Success rate
D010003:Osteoarthritis
174 Companies
53 Drugs
$
Success rate
D010489:Periarthritis
0 Companies
0 Drugs
Success rate
D012213:Rheumatic fever
55 Companies
22 Drugs
$
Success rate
D015535:Psoriatic arthritis
79 Companies
14 Drugs
$
Success rate
D025241:Spondylarthritis
0 Companies
0 Drugs
Success rate
D058566:Sacroiliitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
RocheTocilizumab RoActemra  2009-01-15   
SandozEtanercept Erelzi  2017-06-23   
Adalimumab Halimatoz  2018-07-26   
Adalimumab Hefiya  2018-07-26   
Adalimumab Hyrimoz  2018-07-26   
Boehringer IngelheimAdalimumab Cyltezo  2017-11-10   
AbbVieAdalimumab Humira  2003-09-08 $6,210 M Q3/24-Q2/25 
NovartisCanakinumab Ilaris  2009-10-23 $1,436 M Q2/22-Q2/25 
PfizerAdalimumab Amsparity  2020-02-13   
Etanercept Enbrel  2000-02-02 $830 M Y2023 
Bristol Myers SquibbAbatacept Orencia  2007-05-21 $3,669 M Q3/24-Q2/25 
CelltrionAdalimumab Yuflyma  2021-02-11   
Fresenius KabiAdalimumab Idacio  2019-04-02   
Adalimumab Kromeya  2019-04-02   
Tocilizumab Tyenne  2023-09-15   
Hisamitsu PharmaceuticalMenthol, Methyl salicylate Salonpas 2027-08-01 2008-02-20   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
85%
17/20
Phase 2
43%
9/21
Phase 3
39%
11/28
Approved: 4Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Tocilizumab,
Lornoxicam,
Aspartame,
Bevifimod,
Edodekin alfa,
PERAKIZUMAB,
Globulin, immune,
Bos taurus adrenal cortex corticosteroids,
Cdmard,
Antineoplaston a10,
Solumedrol,
Hidroxicloroquina
Sandoz
Adalimumab,
Etanercept,
Enoblituzumab,
Aspartame,
Nepidermin
Boehringer Ingelheim
Adalimumab,
Doconexent,
AMELUBANT
AbbVie
Adalimumab,
Glucosamine,
Bevifimod,
ELSUBRUTINIB,
REMTOLUMAB,
TREGALIZUMAB,
Globulin, immune,
Streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae crm197,
Prevnar13,
Pcv13,
Pneumovax,
Prevenar
Novartis
Canakinumab,
Benzocaine,
Lumiracoxib,
Ianalumab,
Aspartame,
Bevifimod,
Edodekin alfa,
ISCALIMAB,
Nepidermin,
Globulin, immune,
Bakuchiol,
Stp1,
Histone-arginine methyltransferase carm1,
BFH-772,
Surlorian,
Daivonex,
Demand
Pfizer
Adalimumab,
Etanercept,
Benzocaine,
Methionine,
Tanezumab,
Ademetionine,
Doconexent,
Lornoxicam,
Brepocitinib,
ZIMLOVISERTIB,
Aspartame,
Bevifimod,
FEZAKINUMAB,
Globulin, immune,
Fluzone,
Streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae crm197,
Pneumovax,
Solumedrol,
Histone-arginine methyltransferase carm1,
Flumist,
Pf06700841,
Surlorian,
Flucelvax,
Hidroxicloroquina,
Prevenar,
Varicella-zoster virus strain oka/merck live antigen,
Isoxaflutole
Bristol Myers Squibb
Abatacept,
Benzodiazepine,
Benzimidazole,
Tarenflurbil,
BRANEBRUTINIB,
Bevifimod,
ELDELUMAB,
Lotamilast,
Polyglycolic acid,
Remetinostat,
Usistapide,
Insulin,
Globulin, immune,
Digitalis,
Viaject,
Mevalotin,
Histone-arginine methyltransferase carm1,
Surlorian,
Sominex
Celltrion
Adalimumab
Fresenius Kabi
Adalimumab,
Tocilizumab
Hisamitsu Pharmaceutical
Methyl salicylate
Amgen
Adalimumab,
Benzocaine,
Benzimidazole,
Dexibuprofen,
Dazodalibep,
EFAVALEUKIN ALFA,
Bevifimod,
Ordesekimab,
PEGSUNERCEPT,
Polyglycolic acid,
PREZALUMAB,
ROZIBAFUSP ALFA,
Globulin, immune,
Hidroxicloroquina
Samsung Bioepis
Adalimumab,
Bevifimod,
Globulin, immune,
Hidroxicloroquina
Nordic Pharma
Methotrexate
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use